Subscribe
turbaliska / Shutterstock.com
8 April 2025NewsEuropeLiz Hockley

EPO: Biotech innovation strong, while pharma trails behind

According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Genmab fights claim over 'secrets theft' behind $1.8bn takeover
25 March 2025   Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment pipeline ahead of Genmab acquisition.
Europe
European court upholds 10x patent after Nanostring appealed injunction
20 March 2025   New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Americas
Genmab fights claim over 'secrets theft' behind $1.8bn takeover
25 March 2025   Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment pipeline ahead of Genmab acquisition.
Europe
European court upholds 10x patent after Nanostring appealed injunction
20 March 2025   New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.

More on this story

Americas
Genmab fights claim over 'secrets theft' behind $1.8bn takeover
25 March 2025   Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees helped ProfoundBio use confidential tech to improve its cancer treatment pipeline ahead of Genmab acquisition.
Europe
European court upholds 10x patent after Nanostring appealed injunction
20 March 2025   New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.

More features

Bayer’s Xarelto patent struck down by German court
Teva draws line under asthma inhaler feud with US rival
Xanax owner fends off ‘Canvax’ mark in EU
Four-lawyer team joins Cozen O’Connor’s new San Diego office
WATCH: Beyond patents — the evolving role of IP lawyers in life sciences
Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US